GT
ALDR

Glenmede Trust’s Alder Biopharmaceuticals ALDR Stock Holding History

Glenmede Trust’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-812
Closed -$14 – 3222
2019
Q3 		$14 Buy
812
+781
+2,519% +$8.93K ﹤0.01% 2224
2019
Q2 		$0 Hold
31
– – ﹤0.01% 3259
2019
Q1 		$0 Hold
31
– – ﹤0.01% 3244
2018
Q4 		$0 Buy
+31
New +$397 ﹤0.01% 3133
2016
Q4 		– Sell
-31
Closed -$1K – 2689
2016
Q3 		$1K Buy
+31
New +$944 ﹤0.01% 2531

Glenmede Trust's ALDR Position: Q4 2019 in Review

Glenmede Trust sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 812 shares — an estimated $14 sold.

Glenmede Trust first reported a position in ALDR in Q3 2016 and held it in 5 quarters. The position peaked at $1K in Q3 2016. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Glenmede Trust reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Glenmede Trust sold 812 Alder Biopharmaceuticals shares in Q4 2019, an estimated $14.
  • Glenmede Trust first reported a position in Alder Biopharmaceuticals in Q3 2016 and held it in 5 quarters.
  • Glenmede Trust's Alder Biopharmaceuticals position peaked at $1K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.